Melt Pharmaceuticals (MELT) USPTO patentsUtility application

Utility

Pharmaceutical Compositions and Methods for Anesthesiological Applications

11 Aug 22

Pharmaceutical compositions and methods for inducing conscious sedation using such compositions are described, the compositions including a benzodiazepine-based compound, an NMDA antagonist, and optionally a β-blocker, antiemetic, an NSAID, and/or an antihistamine medication.

Dennis Elias Saadeh

Filed: 29 Apr 22

Utility

Pharmaceutical Compositions Comprising Antiemetics and ALPHA-2-ADRENERGIC Receptor Agonists and Methods of Using the Same for Anesthesiological Applications

3 Feb 22

Pharmaceutical compositions and methods for inducing conscious sedation using such compositions are described, the compositions including antiemetic(s) and a-2-adrenergic receptor agonist(s), and optionally β-blocker(s), NSAID(s), antihistamine(s), and/or pain reliever(s).

Dennis Elias Saadeh

Filed: 28 Jul 20

Utility

6lgna2epyf789120u9upholfi7w3

25 Mar 21

Pharmaceutical compositions and methods of use including a benzodiazepine-based compound, an NMDA antagonist, and optionally a β-blocker, antiemetic, an NSAID, and/or an antihistamine medication.

Dennis Elias Saadeh

Filed: 9 Dec 20

Utility

7dyyaz541tl kxqubq9t2r

23 Sep 20

Pharmaceutical compositions and methods for inducing conscious sedation using such compositions are described, the compositions including a benzodiazepine-based compound, an NMDA antagonist, and optionally a β-blocker, antiemetic, an NSAID, and/or an antihistamine medication.

Dennis Elias Saadeh

Filed: 10 Jun 20

Utility

rqghyxbaq9mgkwibyexpi6qcnpxk jvi

20 May 20

Pharmaceutical compositions and methods for inducing conscious sedation using such compositions are described, the compositions comprising a benzodiazepine-based compound, a NMDA antagonist, and optionally a β-blocker, antiemetic, an NSAID, and/or an antihistamine medication.

John Berdahl, Dennis Elias Saadeh, Mark Baum

Filed: 22 Jan 20